scholarly article | Q13442814 |
P356 | DOI | 10.1186/S12866-015-0605-3 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s12866-015-0605-3 |
P932 | PMC publication ID | 4667461 |
P698 | PubMed publication ID | 26630969 |
P5875 | ResearchGate publication ID | 285618909 |
P50 | author | Han-Dong Sun | Q89167622 |
P2093 | author name string | Ru Bai | |
Hong-Bin Zhang | |||
Yan-Li Li | |||
Yong-Tang Zheng | |||
Wei-Lie Xiao | |||
Xing-Jie Zhang | |||
Li-Xin Liu | |||
Jian-Xin Pu | |||
Jing-Ping Liu | |||
P2860 | cites work | Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens | Q24534391 |
Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection | Q24544232 | ||
Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor | Q24547409 | ||
Active nuclear import of human immunodeficiency virus type 1 preintegration complexes | Q24564507 | ||
The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells | Q24564509 | ||
The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes | Q24564711 | ||
The cell cycle independence of HIV infections is not determined by known karyophilic viral elements | Q24816846 | ||
CPSF6 Defines a Conserved Capsid Interface that Modulates HIV-1 Replication | Q27672646 | ||
Structural and Functional Analysis of the C-Terminal Domain of Nup358/RanBP2 | Q27676012 | ||
Discovery of Novel Small-Molecule HIV-1 Replication Inhibitors That Stabilize Capsid Complexes | Q27678859 | ||
A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells | Q28249434 | ||
HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator | Q28307391 | ||
Fates of retroviral core components during unrestricted and TRIM5-restricted infection | Q28487732 | ||
DB-02, a C-6-cyclohexylmethyl substituted pyrimidinone HIV-1 reverse transcriptase inhibitor with nanomolar activity, displays an improved sensitivity against K103N or Y181C than S-DABOs | Q28535401 | ||
Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein | Q28576921 | ||
The HIV-1 reverse transcription (RT) process as target for RT inhibitors | Q28646665 | ||
Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection | Q28646834 | ||
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys | Q29547689 | ||
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor | Q29547710 | ||
Recruitment and dynamics of proteasome association with rhTRIM5α cytoplasmic complexes during HIV-1 infection | Q30543944 | ||
Human nucleoporins promote HIV-1 docking at the nuclear pore, nuclear import and integration | Q31103609 | ||
Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells | Q33304219 | ||
Flexible use of nuclear import pathways by HIV-1. | Q33739260 | ||
Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. | Q33822095 | ||
Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. | Q33851147 | ||
Structural biology of HIV. | Q34068223 | ||
MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1 | Q34091405 | ||
Capsid is a dominant determinant of retrovirus infectivity in nondividing cells | Q34152408 | ||
Slowly declining levels of viral RNA and DNA in DNA/recombinant modified vaccinia virus Ankara-vaccinated macaques with controlled simian-human immunodeficiency virus SHIV-89.6P challenges | Q34348561 | ||
Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization | Q39641782 | ||
Cellular restriction targeting viral capsids perturbs human immunodeficiency virus type 1 infection of nondividing cells | Q39822140 | ||
Sifuvirtide, a potent HIV fusion inhibitor peptide. | Q39872319 | ||
Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later | Q40005181 | ||
The central DNA flap of the human immunodeficiency virus type 1 is important for viral replication | Q40233853 | ||
Human immunodeficiency virus type 1 KK26-27 matrix mutants display impaired infectivity, circularization and integration but not nuclear import | Q40408087 | ||
A carboxy-terminally truncated human CPSF6 lacking residues encoded by exon 6 inhibits HIV-1 cDNA synthesis and promotes capsid disassembly | Q42126893 | ||
Enabled clinical use of an HIV-1 attachment inhibitor through drug delivery | Q42224900 | ||
The interferon-inducible MxB protein inhibits HIV-1 infection. | Q42267969 | ||
HIV-1 infection requires a functional integrase NLS. | Q44134677 | ||
Inhibition of HIV-1 nuclear import via schiff base formation with arylene bis(methylketone) compounds | Q44173878 | ||
Nuclear import of HIV-1 integrase is inhibited in vitro by styrylquinoline derivatives | Q44973296 | ||
A nucleoprotein complex mediates the integration of retroviral DNA. | Q46128219 | ||
A synthetic peptide bearing the HIV-1 integrase 161-173 amino acid residues mediates active nuclear import and binding to importin alpha: characterization of a functional nuclear localization signal | Q47905706 | ||
Characterization of HIV replication complexes early after cell-to-cell infection | Q71602121 | ||
HIV-1 genome nuclear import is mediated by a central DNA flap | Q73726795 | ||
Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex | Q73910247 | ||
Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle | Q34545869 | ||
Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme | Q34674575 | ||
BI-2 destabilizes HIV-1 cores during infection and Prevents Binding of CPSF6 to the HIV-1 Capsid | Q34738657 | ||
Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins | Q35101356 | ||
The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid. | Q35140243 | ||
Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus | Q35140364 | ||
Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of action | Q35185934 | ||
Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signal | Q35575399 | ||
The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid | Q35784739 | ||
HIV-1 antiretroviral drug therapy | Q35853012 | ||
High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. | Q35859304 | ||
Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways | Q36255858 | ||
Intracellular trafficking of retroviral vectors: obstacles and advances | Q36314656 | ||
Retroviral infection of non-dividing cells: old and new perspectives | Q36346812 | ||
Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17 | Q36437723 | ||
Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha | Q36446606 | ||
Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. | Q36684088 | ||
Mutations M184V and Y115F in HIV-1 reverse transcriptase discriminate against "nucleotide-competing reverse transcriptase inhibitors". | Q36949351 | ||
The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6. | Q36964335 | ||
A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus | Q37002260 | ||
APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells | Q37186249 | ||
Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector | Q37251114 | ||
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes | Q37251604 | ||
Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication. | Q37386004 | ||
Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA. | Q37564101 | ||
The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs | Q37596510 | ||
Antiretroviral therapy and management of HIV infection | Q37770721 | ||
Multiple roles of the capsid protein in the early steps of HIV-1 infection. | Q38049930 | ||
Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexes | Q38150610 | ||
Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1 | Q38288599 | ||
Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells | Q38903364 | ||
N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles | Q39580545 | ||
A rapid in vitro polyomavirus DNA replication assay | Q39631857 | ||
P304 | page(s) | 274 | |
P577 | publication date | 2015-12-02 | |
P1433 | published in | BMC Microbiology | Q15759430 |
P1476 | title | SJP-L-5, a novel small-molecule compound, inhibits HIV-1 infection by blocking viral DNA nuclear entry | |
P478 | volume | 15 |
Q46824083 | A Molecular Basis for the Inhibition of Transient Receptor Potential Vanilloid Type 1 by Gomisin A. |
Q40051104 | Anti-HIV Activities and Mechanism of 12-O-Tricosanoylphorbol-20-acetate, a Novel Phorbol Ester from Ostodes katharinae. |
Q50129893 | SJP-L-5 inhibits HIV-1 polypurine tract primed plus-strand DNA elongation, indicating viral DNA synthesis initiation at multiple sites under drug pressure. |
Search more.